Literature DB >> 18340391

Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Ayşe Yeşim Göçmen1, Emel Sahin, Ender Semiz, Saadet Gümuşlü.   

Abstract

BACKGROUND: An imbalance between the lipid peroxidation process and antioxidative protection is associated with the pathophysiology of coronary artery disease (CAD). The authors aimed to determine the relationship between the contributors of antioxidant protection, such as paraoxonase-1 (PON1) activity, albumin, vitamin C and ceruloplasmin (CP) levels, and lipid peroxidation indicators.
METHODS: In the present study, the activity of PON1 was measured, together with serum concentrations of a variety of lipid constituents, albumin, vitamin C and CP levels, and lipid peroxidation indicators (conjugated dienes [CDs] and thiobarbituric acid-reactive substances [TBARS]). Data were gathered from 26 nondiabetic, angiographically proven, Turkish CAD patients and 26 healthy controls living in the Antalya region (Turkey).
RESULTS: CAD patients had significantly lower PON1 activity, high-density lipoprotein cholesterol, vitamin C and albumin concentrations, and higher CP, CD and TBARS concentrations than the controls. In the entire study population (n=52), serum CP levels were positively correlated with TBARS and CD levels, and negatively correlated with albumin and vitamin C levels, as well as with PON1 activity. On multiple logistic regression analysis, risk factors associated with CAD included high CP and low albumin levels.
CONCLUSIONS: CAD patients and controls were matched for age and sex, and high CP and low albumin levels were found to be independent risk factors for CAD. The present data gathered from the study group living in the Antalya region verifies that in CAD patients, CP impairs the oxidant-antioxidant balance in favour of the oxidants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340391      PMCID: PMC2649635          DOI: 10.1016/s0828-282x(08)70586-5

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  36 in total

Review 1.  Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.

Authors:  J W Heinecke
Journal:  Atherosclerosis       Date:  1998-11       Impact factor: 5.162

2.  Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C.

Authors:  D Halevy; J Thiery; D Nagel; S Arnold; E Erdmann; B Höfling; P Cremer; D Seidel
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

3.  Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients.

Authors:  N Sakuma; T Hibino; T Sato; N Ohte; S Akita; N Tamai; K Sasai; T Yoshimata; T Fujinami
Journal:  Clin Biochem       Date:  1997-08       Impact factor: 3.281

4.  Evidence of oxidative stress in chronic heart failure in humans.

Authors:  J McMurray; M Chopra; I Abdullah; W E Smith; H J Dargie
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

5.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Direct evidence of caeruloplasmin antioxidant properties.

Authors:  R L Atanasiu; D Stea; M A Mateescu; C Vergely; F Dalloz; F Briot; V Maupoil; R Nadeau; L Rochette
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

7.  Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage.

Authors:  W Wasowicz; J Nève; A Peretz
Journal:  Clin Chem       Date:  1993-12       Impact factor: 8.327

8.  Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis.

Authors:  A Enbergs; A Dorszewski; M Luft; G Mönnig; A Kleemann; H Schulte; G Assmann; G Breithardt; S Kerber
Journal:  Coron Artery Dis       Date:  1998       Impact factor: 1.439

Review 9.  Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids.

Authors:  H Sies; W Stahl; A R Sundquist
Journal:  Ann N Y Acad Sci       Date:  1992-09-30       Impact factor: 5.691

10.  Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication.

Authors:  J Cunningham; M Leffell; P Mearkle; P Harmatz
Journal:  Metabolism       Date:  1995-08       Impact factor: 8.694

View more
  10 in total

1.  Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.

Authors:  W H Wilson Tang; Yuping Wu; Jaana Hartiala; Yiying Fan; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Paul L Fox; Hooman Allayee; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

2.  Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.

Authors:  Douglas Ganini; Donatella Canistro; JinJie Jiang; JinJie Jang; Krisztian Stadler; Ronald P Mason; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2012-07-21       Impact factor: 7.376

3.  Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.

Authors:  Muhammad Hammadah; Yiying Fan; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-08-13       Impact factor: 5.712

4.  Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.

Authors:  David J Kennedy; Yiying Fan; Yuping Wu; Michael Pepoy; Stanley L Hazen; W H Wilson Tang
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

5.  Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women.

Authors:  N Tajik; A Golpaie; S A Keshavarz; M Djalali; M Sehat; F Masoudkabir; Z Ahmadivand; F Fatehi; M Zare; T Yazdani
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

6.  Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.

Authors:  Razvan T Dadu; Rhiannon Dodge; Vijay Nambi; Salim S Virani; Ron C Hoogeveen; Nicholas L Smith; Fengju Chen; James S Pankow; Cameron Guild; W H Wilson Tang; Eric Boerwinkle; Stanley L Hazen; Christie M Ballantyne
Journal:  Circ Heart Fail       Date:  2013-07-16       Impact factor: 8.790

Review 7.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

8.  Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran.

Authors:  Seyyed Morteza Safavi; Rahele Ziaei; Mohammad Reza Maracy
Journal:  J Obes       Date:  2012-12-31

9.  Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients.

Authors:  Ewa Romuk; Wojciech Jacheć; Ewa Zbrojkiewicz; Alina Mroczek; Jacek Niedziela; Mariusz Gąsior; Piotr Rozentryt; Celina Wojciechowska
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

10.  Ceruloplasmin and Coronary Heart Disease-A Systematic Review.

Authors:  Antonio P Arenas de Larriva; Laura Limia-Pérez; Juan F Alcalá-Díaz; Alvaro Alonso; José López-Miranda; Javier Delgado-Lista
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.